In response: Diabetes is a risk factor for the progression and prognosis of COVID‐19 von Blanke, Charles D.

Volltext

American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer Prevention von Bailey, Howard H, Chuang, Linus T, duPont, Nefertiti C, Eng, Cathy, Foxhall, Lewis E, Merrill, Janette K, Wollins, Dana S, Blanke, Charles D

Volltext

What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine report von Bertagnolli, Monica M., Blanke, Charles D., Curran, Walter J., Hawkins, Douglas S., Mannel, Robert S., O’Dwyer, Peter J., Schnall, Mitchell D., Wolmark, Norman

Volltext

Phase 2 study of MK‐2206, an allosteric inhibitor of AKT, as second‐line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005)... von Ramanathan, Ramesh K., McDonough, Shannon L., Kennecke, Hagen F., Iqbal, Syma, Baranda, Joaquina C., Seery, Tara E., Lim, Howard J., Hezel, Aram F., Vaccaro, Gina M., Blanke, Charles D.

Volltext

Dual blockade of epidermal growth factor receptor and insulin‐like growth factor receptor–1 signaling in metastatic pancreatic cancer: Phase Ib and randomized phase II trial of gem... von Philip, Philip A., Goldman, Bryan, Ramanathan, Ramesh K., Lenz, Heinz‐Josef, Lowy, Andrew M., Whitehead, Robert P., Wakatsuki, Takeru, Iqbal, Syma, Gaur, Rakesh, Benedetti, Jacqueline K., Blanke, Charles D.

Volltext

Words matter: Restoring respect and dignity when referring to individuals with cancer von Ellis, Lee M., Blanke, Charles D., Kohn, Elise C.

Volltext

Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer von Iqbal, S., Goldman, B., Fenoglio-Preiser, C.M., Lenz, H.J., Zhang, W., Danenberg, K.D., Shibata, S.I., Blanke, C.D.

Volltext

Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials von Unger, Joseph M, Vaidya, Riha, Albain, Kathy S, LeBlanc, Michael, Minasian, Lori M, Gotay, Carolyn C, Henry, N Lynn, Fisch, Michael J, Lee, Shing M, Blanke, Charles D, Hershman, Dawn L

Volltext

Adjuvant imatinib in high-risk resected gastrointestinal stromal tumors: Merely delaying the inevitable? von Sutton, Thomas L, Billingsley, Kevin G, Johnson, Alicia J, Corless, Christopher L, Blanke, Charles D, Heinrich, Michael C, Mayo, Skye C

Volltext

Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection von SMALLEY, Stephen R, BENEDETTI, Jacqueline K, STEMMERMANN, Grant N, BLANKE, Charles D, MACDONALD, John S, HALLER, Daniel G, HUNDAHL, Scott A, ESTES, Norman C, AJANI, Jaffer A, GUNDERSON, Leonard L, GOLDMAN, Bryan, MARTENSON, James A, JESSUP, J. Milburn

Volltext

Gastrointestinal Stromal Tumors: Disease and Treatment Update von Ho, Maria Y, Blanke, Charles D

Volltext

Detecting and estimating intensity of jumps for discretely observed ARMA D ( 1 , 1 ) processes von Blanke, D., Bosq, D.

Volltext

In Memoriam: Charles A. Coltman, 1930 to 2018 von Blanke, Charles D, Crowley, John, Baker, Laurence H, Fisher, Richard I

Volltext

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbla... von Ben-Josef, Edgar, Guthrie, Katherine A, El-Khoueiry, Anthony B, Corless, Christopher L, Zalupski, Mark M, Lowy, Andrew M, Thomas, Jr, Charles R, Alberts, Steven R, Dawson, Laura A, Micetich, Kenneth C, Thomas, Melanie B, Siegel, Abby B, Blanke, Charles D

Volltext

Biomarkers in GIST: Partly Ready for Prime-Time Use von Blanke, Charles D

Volltext

A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer von Chen, Emerson Y, Blanke, Charles D, Haller, Daniel G, Benson, Al B, Dragovich, Tomislav, Lenz, Heinz-Josef, Robles, Carlos, Li, Hong, Mori, Motomi, Mattek, Nora, Sanborn, Rachel E, Lopez, Charles D

Volltext

Detecting and estimating intensity of jumps for discretely observed ARMAD(1,1) processes von Blanke, D., Bosq, D.

Volltext

Imatinib Plasma Levels Are Correlated With Clinical Benefit in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors von DEMETRI, George D, YANFENG WANG, WEHRLE, Elisabeth, RACINE, Amy, NIKOLOVA, Zariana, BLANKE, Charles D, JOENSUU, Heikki, VON MEHREN, Margaret

Volltext

Optimal Duration of Adjuvant Therapy for Patients With Resected Gastrointestinal Stromal Tumors von Blanke, Charles D

Volltext

Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Ex... von BLANKE, Charles D, DEMETRI, George D, WEHRE, Elisabeth, NIKOLOVA, Zariana, JOENSUU, Heikki, VON MEHREN, Margaret, HEINRICH, Michael C, EISENBERG, Burton, FLETCHER, Jonathan A, CORLESS, Christopher L, FLETCHER, Christopher D. M, ROBERTS, Peter J, HEINZ, Daniela

Volltext